PAR 1.96% 26.0¢ paradigm biopharmaceuticals limited..

Ann: Primary Endpoint Achieved in Phase 2 MPS VI Trial, page-3

  1. 62 Posts.
    lightbulb Created with Sketch. 30
    I can't see anything very standout in here, no improvement in GAGS. maybe someone else with more knowledge than me sees more?? please.....
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.